Select Page

US FDA Guidances Published in October 2022

by | Nov 3, 2022 | Guidances, Regulatory

The US FDA has issued a series of guidance’s to assists the sponsor and applicant in the generic drug development. The October month has around 09 new/revised guidance under GDUFA and DCAP provisions. The links of the guidance’s are provided below for quick review and...
Don`t copy text!